Detalhe da pesquisa
1.
Validation of the Observer-Reported Communication Ability (ORCA) measure for individuals with Rett syndrome.
Eur J Paediatr Neurol
; 46: 74-81, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37536121
2.
Saliva MicroRNA Differentiates Children With Autism From Peers With Typical and Atypical Development.
J Am Acad Child Adolesc Psychiatry
; 59(2): 296-308, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30926572
3.
The levo enantiomer of amphetamine increases memory consolidation and gene expression in the hippocampus without producing locomotor stimulation.
Neurobiol Learn Mem
; 92(1): 106-13, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19368765
4.
Validation of a Salivary RNA Test for Childhood Autism Spectrum Disorder.
Front Genet
; 9: 534, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30473705
5.
Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome.
Nat Rev Drug Discov
; 17(4): 280-299, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29217836
6.
Arbaclofen in Children and Adolescents with Autism Spectrum Disorder: A Randomized, Controlled, Phase 2 Trial.
Neuropsychopharmacology
; 42(7): 1390-1398, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-27748740
7.
Arbaclofen in fragile X syndrome: results of phase 3 trials.
J Neurodev Disord
; 9: 3, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28616094
8.
Alvimopan: an oral, peripherally acting, mu-opioid receptor antagonist for the treatment of opioid-induced bowel dysfunction--a 21-day treatment-randomized clinical trial.
J Pain
; 6(3): 184-92, 2005 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-15772912
9.
STX209 (arbaclofen) for autism spectrum disorders: an 8-week open-label study.
J Autism Dev Disord
; 44(4): 958-64, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24272415
10.
Effects of STX209 (arbaclofen) on neurobehavioral function in children and adults with fragile X syndrome: a randomized, controlled, phase 2 trial.
Sci Transl Med
; 4(152): 152ra127, 2012 Sep 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-22993294
11.
Reversal of disease-related pathologies in the fragile X mouse model by selective activation of GABAB receptors with arbaclofen.
Sci Transl Med
; 4(152): 152ra128, 2012 Sep 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-22993295
12.
Modulation of behavioral phenotypes by a muscarinic M1 antagonist in a mouse model of fragile X syndrome.
Psychopharmacology (Berl)
; 217(1): 143-51, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21487657
13.
Mechanism-based approaches to treating fragile X.
Pharmacol Ther
; 127(1): 78-93, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20303363
14.
Temporary increase in leg pain resulting from lumbar sympathetic blockade.
Pain
; 42(2): 201-203, 1990 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-2247317